ArticleJournal of hematology & oncology2023

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

Xiao-Na Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.